Cargando…

Synthesis and Appraisal of Natural Drug-Polymer-Based Matrices Relevant to the Application of Drug-Eluting Coronary Stent Coatings

Cardiovascular diseases are becoming a leading cause of death in the world, and attention is being paid to develop natural drug-based treatment to cure heart diseases. Curcumin, ginger, and magnolol are pharmaceutically active in many ways, having properties including anticoagulation, antiproliferat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghafoor, Bakhtawar, Ali, Murtaza Najabat, Riaz, Zainab
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685865/ https://www.ncbi.nlm.nih.gov/pubmed/33282417 http://dx.doi.org/10.1155/2020/4073091

Ejemplares similares

Evolutionary perspective of drug eluting stents: from thick polymer to polymer free approach
por: Hassan, Sadia, et al.
Publicado: (2022)

Current State of Bioabsorbable Polymer-Coated Drug-Eluting Stents
por: Akinapelli, Abhilash, et al.
Publicado: (2017)

Polymer-free drug-eluting stents versus permanent polymer drug-eluting stents: An updated meta-analysis
por: Chen, Yun-lin, et al.
Publicado: (2019)

Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis
por: Bangalore, Sripal, et al.
Publicado: (2013)

Ureteral stent technology: Drug-eluting stents and stent coatings
por: Yang, Luo, et al.
Publicado: (2015)

Comparison between the Outcomes of Using Biodegradable-Polymer Drug-Eluting Stents and Those of Using Durable-Polymer Drug-Eluting Stents in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
por: Fawzy, Abd-Allah Y., et al.
Publicado: (2019)

Comparison of the safety and efficacy of biodegradable polymer drug-eluting stents versus durable polymer drug-eluting stents: a meta-analysis
por: Lv, Jianfeng, et al.
Publicado: (2015)

Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019)

Comparison between drug-coated balloons and drug-eluting stents in very small coronary artery interventions
por: Tsai, Cheng-Hsuan, et al.
Publicado: (2022)

Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients
por: Funayama, Naohiro, et al.
Publicado: (2022)

Development of a Bioactive Polymeric Drug Eluting Coronary Stent Coating Using Electrospraying
por: McKittrick, C. M., et al.
Publicado: (2019)

Biodegradable polymer-coated thin strut sirolimus-eluting stent versus durable polymer-coated everolimus-eluting stent in the diabetic population
por: Gasior, Pawel, et al.
Publicado: (2021)

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis
por: Nojima, Yuhei, et al.
Publicado: (2014)

State-of-the-Art Stent Technology to Minimize the Risk of Stent Thrombosis and In-Stent Restenosis: Abluminal-Coated Biodegradable Polymer Drug-Eluting Stent
por: Kang, Dong Oh, et al.
Publicado: (2022)

Sirolimus-Eluting Electrospun-Produced Matrices as Coatings for Vascular Stents: Dependence of Drug Release on Matrix Structure and Composition of the External Environment
por: Nazarkina, Zhanna K., et al.
Publicado: (2020)

Outcomes of stenting with overlapping drug-eluting stents versus overlapping drug-eluting and bare-metal stents for the treatment of diffuse coronary lesions
por: Kassaian, SE, et al.
Publicado: (2010)

Efficacy and Safety of Biodegradable Polymer Biolimus-Eluting Stents versus Durable Polymer Drug-Eluting Stents: A Meta-Analysis
por: Ye, Yicong, et al.
Publicado: (2013)

New Biofunctional Loading of Natural Antimicrobial Agent in Biodegradable Polymeric Films for Biomedical Applications
por: Ghafoor, Bakhtawar, et al.
Publicado: (2016)

Drug- and Gene-eluting Stents for Preventing Coronary Restenosis
por: Lekshmi, Kamali Manickavasagam, et al.
Publicado: (2017)

Clinical Outcomes of Polymer-Free Versus Polymer-Coated Drug-Eluting Stents in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis
por: Khatri, Mahima, et al.
Publicado: (2023)

Optimize PLA/EVA Polymers Blend Compositional Coating for Next Generation Biodegradable Drug-Eluting Stents
por: Ishaque, Naila, et al.
Publicado: (2022)

Poly 3-Hydroxybutyrate 4-hydroxybutyrate (P34HB) as a Potential Polymer for Drug-Eluting Coatings on Metal Coronary Stents
por: Jian, Yihui, et al.
Publicado: (2022)

Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions
por: Chieffo, Alaide, et al.
Publicado: (2007)

Exploring alternatives to drug-eluting stents: the potential of combining drug coated balloon with bare-metal stents
por: Murai, Kota, et al.
Publicado: (2023)

Drug-coated balloon combined with drug-eluting stent for the treatment of coronary bifurcation lesions: insights from the HYPER study
por: Pellegrini, Dario, et al.
Publicado: (2023)

In vivo angioscopy evaluation of drug-eluting stent occlusion treated with drug-coated balloon
por: Horikoshi, Takeo, et al.
Publicado: (2023)

Development of biodegradable zein-based bilayer coatings for drug-eluting stents
por: Lenzuni, Martina, et al.
Publicado: (2021)

Comparison of 7-Year, Real-World Clinical Outcomes between Drug-Coated Balloon Angioplasty versus Drug-Eluting Stent Implantation in Patients with Drug-Eluting Stent In-Stent Restenosis
por: Kim, Minsu, et al.
Publicado: (2023)

Biodegradable polymer everolimus-eluting stents versus contemporary drug-eluting stents: a systematic review and meta‑analysis
por: Yin, Juntao, et al.
Publicado: (2023)

Safety and Efficacy of Post-Dilation in Percutaneous Coronary Intervention Using Polymer-Free Ultrathin Strut Sirolimus-Probucol Coated Drug-Eluting Stents
por: Shin, Yonghoon, et al.
Publicado: (2023)

Coronary Stent Thrombosis: Current Insights into New Drug-Eluting Stent Designs
por: Kim, Hyun Kuk, et al.
Publicado: (2012)

The stenting strategy of drug-eluting stents for coronary artery disease in patients on dialysis
por: Fujita, Hiroshi, et al.
Publicado: (2014)

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V(®))
por: Sheiban, Imad, et al.
Publicado: (2008)

Polymer-free versus durable polymer drug-eluting stents in patients with coronary artery disease: A meta-analysis
por: Wu, James J., et al.
Publicado: (2018)

Drug-eluting coronary stents – focus on improved patient outcomes
por: Jaffery, Zehra, et al.
Publicado: (2011)

Next generation drug-eluting stents: focus on bioabsorbable platforms and polymers
por: Doyle, Brendan, et al.
Publicado: (2009)

Comparison of biodegradable and durable polymer drug-eluting stents in acute coronary syndrome: a meta-analysis
por: Yuan, Haoyong, et al.
Publicado: (2022)

Biodegradable polymer drug-eluting stents versus first-generation durable polymer drug-eluting stents: A systematic review and meta-analysis of 12 randomized controlled trials
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2017)

Adverse Events in Primary Percutaneous Coronary Angioplasty With Drug-Eluting Stents Compared With Drug-Coated Balloons: A Retrospective Outlook
por: Sharif Khan, Hamid, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hok64lo6jorpdsoashjtl9t1bg